glycopeptide,neutral_mass,mass_accuracy,ms1_score,ms2_score,q_value,total_signal,start_time,end_time,apex_time,charge_states,msms_count,peptide_start,peptide_end,protein_name,mass_shifts
QLINALQIN(N-Glycosylation)NTAVGHALVLPAGR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},4442.106286536515,-4.905910266220586e-06,11.5413165464,25.1933460286,0,39006951.0,86.2914845254,86.3860777762,86.323031972472,3;4,2,2549,2572,sp|P12111|CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens OX=9606 GN=COL6A3 PE=1 SV=5,Unmodified
LDAPTNLQFVN(N-Glycosylation)ETDSTVLVR{Fuc:1; Hex:5; HexNAc:4},3999.7964099370797,-3.379599688327876e-06,9.04566066648,35.0398963206,0,22228363.25,75.7452779915,75.9018319394,75.792225156848,3,2,996,1016,sp|P02751|FINC_HUMAN Fibronectin OS=Homo sapiens OX=9606 GN=FN1 PE=1 SV=5,Unmodified
LDAPTNLQFVN(N-Glycosylation)ETDSTVLVR{Fuc:3; Hex:5; HexNAc:4},4291.88843518,2.393968232e-06,0,32.2373862314,0,0,,,,3,2,996,1016,sp|P02751|FINC_HUMAN Fibronectin OS=Homo sapiens OX=9606 GN=FN1 PE=1 SV=5,
LDAPTNLQFVN(N-Glycosylation)ETDSTVLVR{Fuc:2; Hex:6; HexNAc:4},4307.91994549,-6.10991991581e-06,0,21.4021445057,0,0,,,,3,1,996,1016,sp|P02751|FINC_HUMAN Fibronectin OS=Homo sapiens OX=9606 GN=FN1 PE=1 SV=5,
LN(N-Glycosylation)YSLPTGQWVGVQLPR{Hex:5; HexNAc:2},3143.46032335,-1.87048897235e-06,0,120.769345303,0,0,,,,3,1,1016,1033,sp|P24821|TENA_HUMAN Tenascin OS=Homo sapiens OX=9606 GN=TNC PE=1 SV=3,
N(N-Glycosylation)LTVPGSLR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3015.2986129409646,-6.168877319465796e-06,11.1801050188,51.1682488514,0,125465449.5,51.8016858564,52.2465008086,51.984148691718,3,2,1118,1127,sp|P24821|TENA_HUMAN Tenascin OS=Homo sapiens OX=9606 GN=TNC PE=1 SV=3,Unmodified
EEQYN(N-Glycosylation)STYR{Fuc:1; Hex:3; HexNAc:4},2633.0475842122405,-3.4121344309937637e-06,14.5507511445,58.9342848354,0,222551198.25,27.0755647725,27.4728779064,27.23841847442,2;3,4,175,184,sp|P01857|IGHG1_HUMAN Immunoglobulin heavy constant gamma 1 OS=Homo sapiens OX=9606 GN=IGHG1 PE=1 SV=2,Unmodified
EEQYN(N-Glycosylation)STYR{Fuc:1; Hex:9; HexNAc:4},3605.3721125978395,-4.59652607325643e-06,11.9019721432,12.0300005227,0,119931727.25,60.1832290596,60.5725623077,60.308181574567,3,1,175,184,sp|P01857|IGHG1_HUMAN Immunoglobulin heavy constant gamma 1 OS=Homo sapiens OX=9606 GN=IGHG1 PE=1 SV=2,Unmodified
GSLSYLN(N-Glycosylation)VTR{Hex:5; HexNAc:2},2325.032725689836,-9.544387186836592e-06,15.8946895462,63.7645374269,0,273326484.125,53.3516580091,53.8477845258,53.584660039965,2,1,256,266,sp|P07339|CATD_HUMAN Cathepsin D OS=Homo sapiens OX=9606 GN=CTSD PE=1 SV=1,Unmodified
N(N-Glycosylation)MSFVNDLTVTQDGRK{Hex:7; HexNAc:2},3364.4310910359513,-5.642921387845599e-06,-4.58983659766,16.3272671867,0,14136637.25,59.6724738068,59.7502571251,59.672473806763,3,1,195,211,sp|Q9HDC9|APMAP_HUMAN Adipocyte plasma membrane-associated protein OS=Homo sapiens OX=9606 GN=APMAP PE=1 SV=2,Unmodified
AEPPLN(N-Glycosylation)ASASDQGEK{Hex:5; HexNAc:2},2729.144192932632,-5.75836161127364e-06,10.6181154887,30.6365936062,0,48630671.875,32.1486722416,32.3987450904,32.19238157533,3,1,925,940,sp|Q9Y4L1|HYOU1_HUMAN Hypoxia up-regulated protein 1 OS=Homo sapiens OX=9606 GN=HYOU1 PE=1 SV=1,Unmodified
LN(N-Glycosylation)RSQRGGR{Fuc:2; Hex:7; HexNAc:4},3281.37049306,2.13358083294e-06,0,16.1156959434,0,0,,,,3,1,14,23,sp|Q86V81|THOC4_HUMAN THO complex subunit 4 OS=Homo sapiens OX=9606 GN=ALYREF PE=1 SV=3,
ALPQPQN(N-Glycosylation)VTSLLGC(Carbamidomethyl)TH{Fuc:2; Hex:5; HexNAc:4; Neu5Ac:1},3940.67020657,-1.28433173164e-06,0,16.2690597791,0,0,,,,3,2,446,462,sp|P02790|HEMO_HUMAN Hemopexin OS=Homo sapiens OX=9606 GN=HPX PE=1 SV=2,
FEDGVLDPDYPRN(N-Glycosylation)ISDGFDGIPDNVDAALALPAHSYSGR{Fuc:2; Hex:5; HexNAc:4; Neu5Ac:1},6380.79963367607,-8.770286788958769e-06,-21.1066069934,30.1863593383,0,7963718,95.3834493743,95.3834493743,95.383449374262,4,1,229,268,sp|P04004|VTNC_HUMAN Vitronectin OS=Homo sapiens OX=9606 GN=VTN PE=1 SV=1,Unmodified
N(N-Glycosylation)ISDGFDGIPDNVDAALALPAHSYSGR{Fuc:2; Hex:5; HexNAc:4; Neu5Ac:1},4977.11742461,-1.90819620299e-06,0,20.5188451891,0,0,,,,4,1,241,268,sp|P04004|VTNC_HUMAN Vitronectin OS=Homo sapiens OX=9606 GN=VTN PE=1 SV=1,
N(N-Glycosylation)GSLFAFR{Fuc:2; Hex:5; HexNAc:4; Neu5Ac:1},3116.26863859,-3.11155899109e-06,0,8.79909219358,0.030303030303,0,,,,3,1,168,176,sp|P04004|VTNC_HUMAN Vitronectin OS=Homo sapiens OX=9606 GN=VTN PE=1 SV=1,
GHVN(N-Glycosylation)ITR{Hex:5; HexNAc:4; Neu5Ac:2},3000.215665416912,-2.6965219651853222e-06,15.2232842883,45.7934059008,0,586849130.5,27.4434482243,28.1758620248,27.591129623477,3,2,117,124,sp|P00734|THRB_HUMAN Prothrombin OS=Homo sapiens OX=9606 GN=F2 PE=1 SV=2,Unmodified
GHTLTLN(N-Glycosylation)FTR{Fuc:3; Hex:8; HexNAc:7; Neu5Ac:1},4605.87141688,-2.06757658385e-06,0,13.3487024501,0,0,,,,3,1,96,106,sp|P11279|LAMP1_HUMAN Lysosome-associated membrane glycoprotein 1 OS=Homo sapiens OX=9606 GN=LAMP1 PE=1 SV=3,
ALGKN(N-Glycosylation)R{Fuc:2; Hex:8; HexNAc:5; Neu5Ac:1},3552.41343799,2.66120631061e-06,0,46.8622371123,0,0,,,,3,1,72,78,sp|Q96GQ7|DDX27_HUMAN Probable ATP-dependent RNA helicase DDX27 OS=Homo sapiens OX=9606 GN=DDX27 PE=1 SV=2,
NC(Carbamidomethyl)LRN(N-Glycosylation)TTGFK{Fuc:1; Hex:7; HexNAc:5; Neu5Ac:1},3796.530278043407,-4.710952853662363e-06,10.8078192021,51.8460773337,0,57598217.125,29.8972558763,30.2076684898,30.074912240728,3,1,210,220,sp|Q16363|LAMA4_HUMAN Laminin subunit alpha-4 OS=Homo sapiens OX=9606 GN=LAMA4 PE=1 SV=4,Unmodified
N(N-Glycosylation)TTGFK{Hex:6; HexNAc:5; Neu5Ac:1},2945.1561232034574,-4.486648131567849e-06,10.3907799016,38.5561845441,0,27951428.0625,22.8778193897,23.4585511075,23.369155957921,3,1,214,220,sp|Q16363|LAMA4_HUMAN Laminin subunit alpha-4 OS=Homo sapiens OX=9606 GN=LAMA4 PE=1 SV=4,Unmodified
N(N-Glycosylation)TTGFK{Fuc:2; Hex:6; HexNAc:5},2946.15173418,3.92927418684e-06,0,7.54659017821,0.0454545454545,0,,,,3,1,214,220,sp|Q16363|LAMA4_HUMAN Laminin subunit alpha-4 OS=Homo sapiens OX=9606 GN=LAMA4 PE=1 SV=4,
LGLSFNSISAVDN(N-Glycosylation)GSLANTPHLR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},4441.9931646591185,-6.542246366060825e-06,14.5256835328,28.8519151833,0,471197911.0,81.6661900904,82.0449667241,81.808138424778,3;4,1,249,272,sp|P07585|PGS2_HUMAN Decorin OS=Homo sapiens OX=9606 GN=DCN PE=1 SV=1,Unmodified
TKTEISEMNRN(N-Glycosylation)ISR{Hex:5; HexNAc:4; Neu5Ac:2},3882.6384064333856,-4.931912831217507e-06,13.2141619145,21.0730814715,0,848862984.25,83.0238964902,84.3005301581,83.734201139832,3,3,302,316,"sp|P05787|K2C8_HUMAN Keratin, type II cytoskeletal 8 OS=Homo sapiens OX=9606 GN=KRT8 PE=1 SV=7",Unmodified
EEQYN(N-Glycosylation)STYR{Fuc:1; Hex:3; HexNAc:4},2633.0475842122405,-3.4121344309937637e-06,14.5507511445,58.9342848354,0,222551198.25,27.0755647725,27.4728779064,27.23841847442,2;3,4,294,303,sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2,Unmodified
EEQYN(N-Glycosylation)STYR{Fuc:1; Hex:9; HexNAc:4},3605.3721125978395,-4.59652607325643e-06,11.9019721432,12.0300005227,0,119931727.25,60.1832290596,60.5725623077,60.308181574567,3,1,294,303,sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2,Unmodified
LQLSNGN(N-Glycosylation)M(Oxidation)TLTLLSVK{Hex:5; HexNAc:2},2963.38644712722,-2.9067194014619498e-06,12.7264788672,50.5700940217,0,47401457.5,76.3716908243,76.4946458088,76.449152106667,3,2,190,206,sp|P40199|CEAM6_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 6 OS=Homo sapiens OX=9606 GN=CEACAM6 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)MTLTLLSVK{Hex:5; HexNAc:2},2947.3990134850933,-5.460777682215813e-06,13.0092612605,45.3654385433,0,171453929.25,84.680159476,85.1369148241,84.838761423651,3,3,190,206,sp|P40199|CEAM6_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 6 OS=Homo sapiens OX=9606 GN=CEACAM6 PE=1 SV=4,Unmodified
RVN(N-Glycosylation)TTQKR{Fuc:2; Hex:7; HexNAc:5},3443.4588126357166,-9.70817378321737e-07,12.0443246655,59.1022199725,0,141680630.25,82.7386919763,83.2602742738,82.992228558286,3,3,113,121,sp|P36578|RL4_HUMAN Large ribosomal subunit protein uL4 OS=Homo sapiens OX=9606 GN=RPL4 PE=1 SV=5,Unmodified
WHRRVN(N-Glycosylation)TTQK{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},3675.5477900324154,-1.6842933105015161e-06,13.1074862054,47.5787482414,0,75215486.75,32.0458765573,32.3403252906,32.207312375927,3,2,110,120,sp|P36578|RL4_HUMAN Large ribosomal subunit protein uL4 OS=Homo sapiens OX=9606 GN=RPL4 PE=1 SV=5,Unmodified
RVN(N-Glycosylation)TTQKR{Fuc:1; Hex:6; HexNAc:5; Neu5Ac:2},3718.53170158,-0.000267882916719,0,11.858619931,0,0,,,,3,1,113,121,sp|P36578|RL4_HUMAN Large ribosomal subunit protein uL4 OS=Homo sapiens OX=9606 GN=RPL4 PE=1 SV=5,
MIEN(N-Glycosylation)GSLSFLPTLR{Fuc:3; Hex:5; HexNAc:4},3637.60478131,-5.80984640183e-06,0,24.8218088053,0,0,,,,3,2,266,280,sp|P21810|PGS1_HUMAN Biglycan OS=Homo sapiens OX=9606 GN=BGN PE=1 SV=2,
LLQVVYLHSNN(N-Glycosylation)ITK{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},3991.786458498892,-7.795615661337435e-06,11.7481790034,18.3993257269,0,107201904.25,65.412559639,65.8805438068,65.678022458776,3,4,300,314,sp|P21810|PGS1_HUMAN Biglycan OS=Homo sapiens OX=9606 GN=BGN PE=1 SV=2,Unmodified
M(Oxidation)IEN(N-Glycosylation)GSLSFLPTLR{Fuc:3; Hex:5; HexNAc:4},3653.5998092879395,-5.81533402904663e-06,11.1328450758,17.9408926281,0,56669605.0,86.1332641747,86.4330569572,86.338830342515,3,3,266,280,sp|P21810|PGS1_HUMAN Biglycan OS=Homo sapiens OX=9606 GN=BGN PE=1 SV=2,Unmodified
HN(N-Glycosylation)STGC(Carbamidomethyl)LR{Hex:5; HexNAc:4; Neu5Ac:2},3148.216479526213,-4.650563532795043e-06,14.9039244392,50.6116513249,0,169530579.0,24.3621050583,24.7759801891,24.525611276054,3,2,289,297,sp|P10909|CLUS_HUMAN Clusterin OS=Homo sapiens OX=9606 GN=CLU PE=1 SV=1,Unmodified
KKEDALN(N-Glycosylation)ETR{Fuc:2; Hex:8; HexNAc:5; Neu5Ac:1},4097.6494087,1.6570369966e-06,0,11.8054161523,0,0,,,,3,1,79,89,sp|P10909|CLUS_HUMAN Clusterin OS=Homo sapiens OX=9606 GN=CLU PE=1 SV=1,
N(N-Glycosylation)LTVNYKK{Hex:3; HexNAc:4},2277.0321283117755,-2.7832251889557507e-06,11.1964873158,9.13917628188,0.030303030303,25699549.375,43.962799508,44.1433733092,44.0369274086,2,1,253,261,"sp|Q9Y6N5|SQOR_HUMAN Sulfide:quinone oxidoreductase, mitochondrial OS=Homo sapiens OX=9606 GN=SQOR PE=1 SV=1",Unmodified
TLTLFN(N-Glycosylation)VTR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3123.3485658148165,-3.5343493446588015e-06,11.6435841036,103.361145392,0,301035290.0,70.9295198427,71.3954313423,71.348579739157,3,3,554,563,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
TLTLFN(N-Glycosylation)VTR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3123.3485658148165,-3.5343493446588015e-06,11.6435841036,103.361145392,0,301035290.0,70.9295198427,71.3954313423,71.348579739157,3,3,198,207,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:3; HexNAc:2},1792.8027495576302,-4.354126047754931e-06,11.9163598796,75.0005557418,0,58686244.75,29.6014821079,29.8236837731,29.676283290609,2,1,546,554,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:3; HexNAc:2},1792.8027495576302,-4.354126047754931e-06,11.9163598796,75.0005557418,0,58686244.75,29.6014821079,29.8236837731,29.676283290609,2,1,190,198,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
TLTLFN(N-Glycosylation)VTR{Fuc:3; Hex:6; HexNAc:5},3489.49356148,-9.85140207173e-07,0,54.1021795519,0,0,,,,3,1,198,207,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,
TLTLFN(N-Glycosylation)VTR{Fuc:3; Hex:6; HexNAc:5},3489.49356148,-9.85140207173e-07,0,54.1021795519,0,0,,,,3,1,554,563,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,
LQLSNGN(N-Glycosylation)R{Hex:5; HexNAc:4},2523.0719265133503,-4.990412171077687e-06,12.8975482054,44.9245702585,0,71212780.0,28.8809047407,29.0899088568,28.971066739782,3,2,190,198,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:5; HexNAc:4},2523.0719265133503,-4.990412171077687e-06,12.8975482054,44.9245702585,0,71212780.0,28.8809047407,29.0899088568,28.971066739782,3,2,546,554,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
N(N-Glycosylation)LTKLK{Hex:9; HexNAc:4},2986.264474311055,-4.135230188605463e-06,15.2519869032,38.9831880994,0,207245530.75,43.0274777081,43.5269950734,43.222855491066,3,1,1023,1029,sp|P35749|MYH11_HUMAN Myosin-11 OS=Homo sapiens OX=9606 GN=MYH11 PE=1 SV=3,Unmodified
THAN(N-Glycosylation)GSIKRGSK{Hex:3; HexNAc:2},2146.9828194881325,6.370484702241315e-06,12.4891346956,11.4665941988,0,65237752.125,53.7538646247,54.0459364917,53.924031240368,2,2,2113,2125,sp|Q07954|LRP1_HUMAN Prolow-density lipoprotein receptor-related protein 1 OS=Homo sapiens OX=9606 GN=LRP1 PE=1 SV=2,Unmodified
LLLSIN(N-Glycosylation)VTNTR{Fuc:1; Hex:6; HexNAc:8},3985.75420816,-3.71145352101e-06,0,9.33642691146,0.00934579439252,0,,,,3,1,650,661,sp|P26006|ITA3_HUMAN Integrin alpha-3 OS=Homo sapiens OX=9606 GN=ITGA3 PE=1 SV=5,
N(N-Glycosylation)ATVVWMKDNIR{Hex:7; HexNAc:4; Neu5Ac:1},3683.52231799,1.43098652718e-06,0,14.8643960995,0,0,,,,3,1,360,372,sp|Q13740|CD166_HUMAN CD166 antigen OS=Homo sapiens OX=9606 GN=ALCAM PE=1 SV=2,
KN(N-Glycosylation)LTLM(Oxidation)ATTSQLPK{Fuc:3; Hex:6; HexNAc:5},3986.73492544,1.78918623209e-06,0,10.0193278153,0,0,,,,3,1,265,279,sp|P11117|PPAL_HUMAN Lysosomal acid phosphatase OS=Homo sapiens OX=9606 GN=ACP2 PE=1 SV=3,
TVDKKN(N-Glycosylation)ISEK{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3220.386231692946,-3.476966658762831e-06,12.0748698133,38.8214376294,0,47285759.5,41.2833975421,41.6299704578,41.599440124257,3,2,1293,1303,sp|Q14966|ZN638_HUMAN Zinc finger protein 638 OS=Homo sapiens OX=9606 GN=ZNF638 PE=1 SV=2,Unmodified
KHELLN(N-Glycosylation)STR{Fuc:1; Hex:5; HexNAc:7; Neu5Ac:1},3765.569088338693,7.615400275774198e-07,11.5950460162,53.8352350739,0,76805149.75,38.060458623,38.4354169752,38.207558606688,3,2,434,443,sp|P78347|GTF2I_HUMAN General transcription factor II-I OS=Homo sapiens OX=9606 GN=GTF2I PE=1 SV=2,Unmodified
KHELLN(N-Glycosylation)STR{Fuc:1; Hex:6; HexNAc:6; Neu5Ac:2},4015.6507174303492,-2.4638733060379816e-06,10.8525995618,40.4849783721,0,273841490.625,40.4324060585,41.3741317576,40.744372656568,3;4,1,434,443,sp|P78347|GTF2I_HUMAN General transcription factor II-I OS=Homo sapiens OX=9606 GN=GTF2I PE=1 SV=2,Unmodified
ALVN(N-Glycosylation)FTR{Hex:7; HexNAc:5; Neu5Ac:2},3551.434863101533,-4.819560975555109e-06,10.3366577889,59.4445463587,0,188696255.0,67.1184051579,67.9028883404,67.401983057086,3,2,85,92,sp|P98160|PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens OX=9606 GN=HSPG2 PE=1 SV=4,Unmodified
N(N-Glycosylation)MTLFSDLVAEK{Fuc:1; Hex:4; HexNAc:5},3176.361410078537,-4.751476560310166e-06,-4.58157433689,17.2332614508,0,12126741.5,78.8570032424,78.9837617741,78.952348091825,3,1,784,796,sp|P12110|CO6A2_HUMAN Collagen alpha-2(VI) chain OS=Homo sapiens OX=9606 GN=COL6A2 PE=1 SV=4,Unmodified
N(N-Glycosylation)MTLFSDLVAEK{Hex:7; HexNAc:6},3719.53109755,-1.30282601308e-06,0,10.0372956372,0,0,,,,3,2,784,796,sp|P12110|CO6A2_HUMAN Collagen alpha-2(VI) chain OS=Homo sapiens OX=9606 GN=COL6A2 PE=1 SV=4,
GSTRFN(N-Glycosylation)K{Hex:7; HexNAc:2},2348.932914047408,6.2775695738570935e-06,15.1270487468,58.6769171205,0,272517442.75,29.1338556077,29.7647508925,29.482673874124,2,1,2939,2946,sp|Q16787|LAMA3_HUMAN Laminin subunit alpha-3 OS=Homo sapiens OX=9606 GN=LAMA3 PE=1 SV=3,Unmodified
GSTRFN(N-Glycosylation)K{Hex:6; HexNAc:2},2186.8789759233023,7.252479708343969e-06,12.6962053063,8.76899091476,0.030303030303,146902545.5,29.4396484401,30.1043769425,29.868308658028,2,2,2939,2946,sp|Q16787|LAMA3_HUMAN Laminin subunit alpha-3 OS=Homo sapiens OX=9606 GN=LAMA3 PE=1 SV=3,Unmodified
ASN(N-Glycosylation)VTNKTDPR{Hex:6; HexNAc:6; Neu5Ac:2},3974.56847629,5.19449255507e-06,0,10.274092434,0,0,,,,3,1,1,12,sp|P07910|HNRPC_HUMAN Heterogeneous nuclear ribonucleoproteins C1/C2 OS=Homo sapiens OX=9606 GN=HNRNPC PE=1 SV=4,
ASNVTN(N-Glycosylation)KTDPR{Hex:6; HexNAc:6; Neu5Ac:2},3974.56847629,5.19449255507e-06,0,10.274092434,0,0,,,,3,1,1,12,sp|P07910|HNRPC_HUMAN Heterogeneous nuclear ribonucleoproteins C1/C2 OS=Homo sapiens OX=9606 GN=HNRNPC PE=1 SV=4,
LPGREN(N-Glycosylation)K{Fuc:1; Hex:7; HexNAc:7; Neu5Ac:1},3805.5603333771105,-8.194774471671378e-06,10.5962884333,53.1086083235,0,19362966.5,72.9783331063,73.0880976425,73.024991439406,3,1,71,78,sp|Q07020|RL18_HUMAN Large ribosomal subunit protein eL18 OS=Homo sapiens OX=9606 GN=RPL18 PE=1 SV=2,Unmodified
HRN(N-Glycosylation)RSFSR{Fuc:6; Hex:8; HexNAc:8},4855.965229372165,-2.4714548514374656e-06,8.14492358666,77.0738952623,0,34150025.5,72.5061910894,72.756780623,72.506191089376,4,2,166,174,sp|O75494|SRS10_HUMAN Serine/arginine-rich splicing factor 10 OS=Homo sapiens OX=9606 GN=SRSF10 PE=1 SV=1,Unmodified
AVPVPN(N-Glycosylation)MTPSGVGR{Fuc:1; Hex:6; HexNAc:5; Neu5Ac:1},3805.60093516,-4.05646848254e-06,0,12.1006903798,0,0,,,,3,1,406,420,sp|Q6P996|PDXD1_HUMAN Pyridoxal-dependent decarboxylase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PDXDC1 PE=1 SV=2,
LIVEN(N-Glycosylation)LSSRVSWQDLK{Fuc:1; Hex:5; HexNAc:4},3654.65349181,3.33433429663e-06,0,13.2222226205,0,0,,,,3,1,109,125,sp|Q13243|SRSF5_HUMAN Serine/arginine-rich splicing factor 5 OS=Homo sapiens OX=9606 GN=SRSF5 PE=1 SV=1,
TN(N-Glycosylation)ATKEKMDK{Fuc:3; Hex:6; HexNAc:8},4199.72717965,-4.91928921703e-06,0,11.1882346559,0,0,,,,3,1,1485,1495,sp|P07942|LAMB1_HUMAN Laminin subunit beta-1 OS=Homo sapiens OX=9606 GN=LAMB1 PE=1 SV=2,
IIVPLNNREN(N-Glycosylation)ISDPTSPLR{Fuc:1; Hex:5; HexNAc:3; Neu5Ac:1},4003.849861828087,-6.103146778952912e-06,9.06335341614,18.0324654095,0,52441216.75,66.9146315402,67.1341201729,67.039926007017,3,1,61,80,sp|P01591|IGJ_HUMAN Immunoglobulin J chain OS=Homo sapiens OX=9606 GN=JCHAIN PE=1 SV=4,Unmodified
IIVPLNNREN(N-Glycosylation)ISDPTSPLR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},4498.030528893732,-6.7394213662450305e-06,11.8651164667,12.0767093947,0,25911969.5,68.9302819755,69.0397197908,68.962130223338,4,2,61,80,sp|P01591|IGJ_HUMAN Immunoglobulin J chain OS=Homo sapiens OX=9606 GN=JCHAIN PE=1 SV=4,Unmodified
ALLN(N-Glycosylation)NSHYYHM(Oxidation)AHGK{Fuc:2; Hex:5; HexNAc:4},3685.55734315,-9.19687205334e-06,0,14.3734272061,0,0,,,,3,1,89,104,"sp|P09622|DLDH_HUMAN Dihydrolipoyl dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=DLD PE=1 SV=2",
SRLQN(N-Glycosylation)FSR{Fuc:1; Hex:8; HexNAc:5; Neu5Ac:2},4046.605412866708,-1.5802710286405848e-06,12.1644046787,41.1617791705,0,292930504.375,32.134156941,33.1670630759,32.618796506151,3;4,1,3822,3830,sp|Q63HN8|RN213_HUMAN E3 ubiquitin-protein ligase RNF213 OS=Homo sapiens OX=9606 GN=RNF213 PE=1 SV=3,Unmodified
TALIN(N-Glycosylation)STGEEVAMR{Fuc:1; Hex:9; HexNAc:4},3908.61747196,-0.000262693801037,0,12.631446797,0,0,,,,3,1,527,541,sp|P02545|LMNA_HUMAN Prelamin-A/C OS=Homo sapiens OX=9606 GN=LMNA PE=1 SV=1,
GSAGPM(Oxidation)RLYVGSLHFN(N-Glycosylation)ITEDM(Oxidation)LR{Fuc:1; Hex:9; HexNAc:4},5012.069554385477,7.708106426659477e-06,-20.2804436871,8.92613372396,0,11923422.5,68.7104070093,68.7736027227,68.773602722708,4;5,2,244,267,sp|Q14498|RBM39_HUMAN RNA-binding protein 39 OS=Homo sapiens OX=9606 GN=RBM39 PE=1 SV=2,Unmodified
VARVKAPN(N-Glycosylation)K{Hex:8; HexNAc:4; Neu5Ac:2},3672.536829143937,6.61590569535291e-07,15.0186751518,49.3887676557,0,500088279.5,39.8188492761,40.5661343918,40.074343906466,3,2,657,666,sp|O43290|SNUT1_HUMAN U4/U6.U5 tri-snRNP-associated protein 1 OS=Homo sapiens OX=9606 GN=SART1 PE=1 SV=1,Unmodified
DVLN(N-Glycosylation)DTAPR{Fuc:1; Hex:6; HexNAc:8; Neu5Ac:1},4033.59919852556,1.1331406257302532e-06,9.57849631416,58.1411450922,0,36553760.25,47.3354650404,47.5764254914,47.531987773005,4,1,558,567,sp|P47897|SYQ_HUMAN Glutamine--tRNA ligase OS=Homo sapiens OX=9606 GN=QARS1 PE=1 SV=1,Unmodified
QDSLVINLN(N-Glycosylation)RSNPK{Hex:5; HexNAc:4; Neu5Ac:2},3801.63545005,-1.22099834955e-06,0,13.4315031618,0,0,,,,3,1,647,661,sp|Q9Y5B9|SP16H_HUMAN FACT complex subunit SPT16 OS=Homo sapiens OX=9606 GN=SUPT16H PE=1 SV=1,
LQLSNGN(N-Glycosylation)R{Hex:3; HexNAc:2},1792.8027495576302,-4.354126047754931e-06,11.9163598796,75.0005557418,0,58686244.75,29.6014821079,29.8236837731,29.676283290609,2,1,190,198,sp|P13688|CEAM1_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 1 OS=Homo sapiens OX=9606 GN=CEACAM1 PE=1 SV=2,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:5; HexNAc:4},2523.0719265133503,-4.990412171077687e-06,12.8975482054,44.9245702585,0,71212780.0,28.8809047407,29.0899088568,28.971066739782,3,2,190,198,sp|P13688|CEAM1_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 1 OS=Homo sapiens OX=9606 GN=CEACAM1 PE=1 SV=2,Unmodified
LEN(N-Glycosylation)VSVALEFLER{Hex:3; HexNAc:2},2410.14371332241,-7.277473165941731e-06,-21.2889929796,9.3998398082,0.00934579439252,1937879.5,90.1460637913,90.1460637913,90.146063791339,2,1,96,109,sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3,Unmodified
IMGPN(N-Glycosylation)YTPGKK{Fuc:1; Hex:6; HexNAc:4; Neu5Ac:1},3426.4335762409814,-5.3674362458044074e-06,12.7402286593,92.3466817504,0,344238053.0,82.5178132759,83.3078542418,82.992228558286,3,2,428,439,sp|P13639|EF2_HUMAN Elongation factor 2 OS=Homo sapiens OX=9606 GN=EEF2 PE=1 SV=4,Unmodified
IMGPN(N-Glycosylation)YTPGKK{Hex:6; HexNAc:4},2989.3114646448844,-1.659407983107438e-05,10.0991788758,23.2851050292,0,62761677.25,79.2218286421,79.8997208065,79.521374959373,3,2,428,439,sp|P13639|EF2_HUMAN Elongation factor 2 OS=Homo sapiens OX=9606 GN=EEF2 PE=1 SV=4,Unmodified
SLGPPGPPFN(N-Glycosylation)ITPRK{Fuc:1; Hex:5; HexNAc:4},3345.4999576805235,3.622740059588899e-06,7.65845796306,16.0184631274,0,26087299.5,29.2222326424,29.4255472567,29.222232642396,4,1,1769,1784,sp|Q9NZM1|MYOF_HUMAN Myoferlin OS=Homo sapiens OX=9606 GN=MYOF PE=1 SV=1,Unmodified
FTN(N-Glycosylation)ASK{Hex:6; HexNAc:5; Neu5Ac:1},2945.1561232034574,-4.486648131567849e-06,10.3907799016,38.5561845441,0,27951428.0625,22.8778193897,23.4585511075,23.369155957921,3,1,377,383,sp|P08575|PTPRC_HUMAN Receptor-type tyrosine-protein phosphatase C OS=Homo sapiens OX=9606 GN=PTPRC PE=1 SV=3,Unmodified
LPQKN(N-Glycosylation)SSEGNK{Fuc:3; Hex:5; HexNAc:4; Neu5Ac:1},3552.4628977,-6.4267625202e-07,0,13.9484756746,0,0,,,,3,1,1147,1158,sp|P08575|PTPRC_HUMAN Receptor-type tyrosine-protein phosphatase C OS=Homo sapiens OX=9606 GN=PTPRC PE=1 SV=3,
FTN(N-Glycosylation)ASK{Fuc:2; Hex:6; HexNAc:5},2946.15173418,3.92927418684e-06,0,7.54659017821,0.0454545454545,0,,,,3,1,377,383,sp|P08575|PTPRC_HUMAN Receptor-type tyrosine-protein phosphatase C OS=Homo sapiens OX=9606 GN=PTPRC PE=1 SV=3,
ISESLRTVN(N-Glycosylation)MTWNK{Fuc:2; Hex:5; HexNAc:4; Neu5Ac:1},3883.64296345,1.84875956997e-07,0,11.4069126384,0,0,,,,3,1,2159,2173,sp|P46939|UTRN_HUMAN Utrophin OS=Homo sapiens OX=9606 GN=UTRN PE=1 SV=2,
IIQRN(N-Glycosylation)R{Fuc:2; Hex:6; HexNAc:6},3281.38727692,1.26042355876e-06,0,127.278933867,0,0,,,,3,1,582,588,"sp|P13807|GYS1_HUMAN Glycogen [starch] synthase, muscle OS=Homo sapiens OX=9606 GN=GYS1 PE=1 SV=2",
EEGIN(N-Glycosylation)KSEKR{Fuc:2; Hex:5; HexNAc:4; Neu5Ac:2},3686.49961501,-0.000271664937094,0,8.90501579325,0.0267857142857,0,,,,3,1,512,522,sp|P09874|PARP1_HUMAN Poly [ADP-ribose] polymerase 1 OS=Homo sapiens OX=9606 GN=PARP1 PE=1 SV=4,
N(N-Glycosylation)LTLSK{Hex:8; HexNAc:7; Neu5Ac:2},3975.6058909,-0.000261739459332,0,38.7580546964,0,0,,,,3,1,925,931,sp|Q96Q89|KI20B_HUMAN Kinesin-like protein KIF20B OS=Homo sapiens OX=9606 GN=KIF20B PE=1 SV=3,
N(N-Glycosylation)LTLSK{Fuc:2; Hex:8; HexNAc:7},3684.49392562,-9.8332947036e-07,0,38.3200820594,0,0,,,,3,1,925,931,sp|Q96Q89|KI20B_HUMAN Kinesin-like protein KIF20B OS=Homo sapiens OX=9606 GN=KIF20B PE=1 SV=3,
SITNN(N-Glycosylation)VSQIKLM(Oxidation)HTK{Fuc:1; Hex:5; HexNAc:5},3700.6550796238153,-4.576669270951828e-06,-5.1517712974,14.7792274565,0,8275460.25,79.9155541247,80.026804108,80.026804108047,3,2,973,988,sp|Q96Q89|KI20B_HUMAN Kinesin-like protein KIF20B OS=Homo sapiens OX=9606 GN=KIF20B PE=1 SV=3,Unmodified
ELQRHN(N-Glycosylation)R{Hex:6; HexNAc:4; Neu5Ac:1},3027.23739301,-2.53872171646e-06,0,20.6243089402,0,0,,,,3,1,246,253,sp|P40222|TXLNA_HUMAN Alpha-taxilin OS=Homo sapiens OX=9606 GN=TXLNA PE=1 SV=3,
LPTSALVN(N-Glycosylation)LSHGSR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},3801.63981172,-5.32318990028e-06,0,12.2621686713,0,0,,,,3,1,1163,1177,sp|Q8IZH2|XRN1_HUMAN 5'-3' exoribonuclease 1 OS=Homo sapiens OX=9606 GN=XRN1 PE=1 SV=1,
LPTSALVN(N-Glycosylation)LSHGSR{Fuc:3; Hex:5; HexNAc:5; Neu5Ac:1},4005.740168624101,-5.197577292725317e-06,-7.34863383364,12.0525298409,0,9127077.25,57.6782920744,58.0498782899,58.049878289922,3;4,1,1163,1177,sp|Q8IZH2|XRN1_HUMAN 5'-3' exoribonuclease 1 OS=Homo sapiens OX=9606 GN=XRN1 PE=1 SV=1,Unmodified
AQN(N-Glycosylation)ISSNANMLRK{Hex:6; HexNAc:5; Neu5Ac:1},3724.549867808556,6.647828143900542e-08,13.1994933859,15.4154559716,0,70623539.25,37.9580440746,38.2680703746,38.132609592501,3,1,1441,1454,sp|Q14008|CKAP5_HUMAN Cytoskeleton-associated protein 5 OS=Homo sapiens OX=9606 GN=CKAP5 PE=1 SV=3,Unmodified
LEREERN(N-Glycosylation)QTQVLR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},4020.736763184958,-5.0822518289568565e-06,10.1915752749,12.0246936806,0,88474835.0,46.1109445399,46.3827838566,46.246174957975,3;4,3,277,290,sp|Q96CS3|FAF2_HUMAN FAS-associated factor 2 OS=Homo sapiens OX=9606 GN=FAF2 PE=1 SV=2,Unmodified
LERN(N-Glycosylation)FTVSAVIFK{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},3873.693460859967,-3.1877492765693802e-06,11.911564462,13.7327845455,0,101231778.5,49.3485738582,49.6062991923,49.455904192352,3;4,2,151,164,sp|Q08999|RBL2_HUMAN Retinoblastoma-like protein 2 OS=Homo sapiens OX=9606 GN=RBL2 PE=1 SV=3,Unmodified
HARWFEEN(N-Glycosylation)ASQSTVK{Fuc:3; Hex:8; HexNAc:8},5148.05048397667,6.828846892498e-06,-21.777356819,34.1804454142,0,8778115,75.2932155079,75.2932155079,75.293215507889,4,2,206,221,sp|Q12905|ILF2_HUMAN Interleukin enhancer-binding factor 2 OS=Homo sapiens OX=9606 GN=ILF2 PE=1 SV=2,Unmodified
AKVIAAEGEMN(N-Glycosylation)ASR{Fuc:2; Hex:7; HexNAc:4; Neu5Ac:1},3975.62634508,4.5412652317e-07,0,11.8924118659,0,0,,,,3,1,218,232,sp|P27105|STOM_HUMAN Stomatin OS=Homo sapiens OX=9606 GN=STOM PE=1 SV=3,
DVLRN(N-Glycosylation)VSLRAK{Fuc:3; Hex:6; HexNAc:7; Neu5Ac:3},4975.09072521,-1.30308579031e-06,0,10.8206737992,0,0,,,,4,1,2423,2434,sp|A8TX70|CO6A5_HUMAN Collagen alpha-5(VI) chain OS=Homo sapiens OX=9606 GN=COL6A5 PE=1 SV=1,
EKDVLHEN(N-Glycosylation)STLREEIAMLR{Fuc:1; Hex:3; HexNAc:4},3726.7262975654285,-6.31884903228071e-06,-4.23500084459,11.5445530191,0,9503410.25,79.757317641,79.8053157594,79.805315759404,3,2,640,659,sp|Q6S8J3|POTEE_HUMAN POTE ankyrin domain family member E OS=Homo sapiens OX=9606 GN=POTEE PE=2 SV=3,Unmodified
EN(N-Glycosylation)LSPK{Hex:8; HexNAc:4},2795.104042610033,-1.452799921398041e-06,13.7294129947,62.1010756955,0,159911287.625,26.9000942733,27.3410738733,27.075564772511,3,2,431,437,sp|A0FGR8|ESYT2_HUMAN Extended synaptotagmin-2 OS=Homo sapiens OX=9606 GN=ESYT2 PE=1 SV=1,Unmodified
INLELRN(N-Glycosylation)R{Fuc:1; Hex:9; HexNAc:4},3444.47594875,-0.000299526688246,0,13.8158102941,0,0,,,,3,2,6,14,sp|Q9BTT0|AN32E_HUMAN Acidic leucine-rich nuclear phosphoprotein 32 family member E OS=Homo sapiens OX=9606 GN=ANP32E PE=1 SV=1,
GRN(N-Glycosylation)WSRER{Hex:5; HexNAc:2},2275.948852755184,2.738521403214461e-06,13.1285709782,62.5026953898,0,79254604.75,63.826035975,64.120337473,63.950483789666,2,2,2119,2127,sp|Q9BTC0|DIDO1_HUMAN Death-inducer obliterator 1 OS=Homo sapiens OX=9606 GN=DIDO1 PE=1 SV=5,Unmodified
LN(N-Glycosylation)LTTDPK{Hex:5; HexNAc:4; Neu5Ac:1},2814.1687855454074,-4.085248845443752e-08,10.7479186332,56.3081440793,0,142001448.5,30.353985193,31.0320642577,30.693511492634,3,2,163,171,sp|Q92896|GSLG1_HUMAN Golgi apparatus protein 1 OS=Homo sapiens OX=9606 GN=GLG1 PE=1 SV=2,Unmodified
LN(N-Glycosylation)LTTDPK{Hex:7; HexNAc:6},3253.3339770269436,1.1277422613235339e-06,13.6323810575,56.2984692055,0,51263015.0,28.1468119409,28.3526732073,28.205944075807,3,2,163,171,sp|Q92896|GSLG1_HUMAN Golgi apparatus protein 1 OS=Homo sapiens OX=9606 GN=GLG1 PE=1 SV=2,Unmodified
LLKEN(N-Glycosylation)TTLLK{Fuc:1; Hex:8; HexNAc:4},3427.524453225039,-0.0002943357305472821,14.1593336952,15.2714002636,0,549724470.0,69.2122874763,69.5532901393,69.366774990781,3;4,1,439,449,sp|P29536|LMOD1_HUMAN Leiomodin-1 OS=Homo sapiens OX=9606 GN=LMOD1 PE=1 SV=3,Unmodified
N(N-Glycosylation)LTFNITKTIR{Fuc:3; Hex:5; HexNAc:4; Neu5Ac:1},3671.5962817751742,2.8878860941078087e-06,14.3984974911,16.2311516497,0,210278678,38.9475396063,39.1911326395,39.00753759009,3,2,147,158,sp|H3BS89|T178B_HUMAN Transmembrane protein 178B OS=Homo sapiens OX=9606 GN=TMEM178B PE=2 SV=1,Unmodified
KLSPFN(N-Glycosylation)ITHR{Fuc:1; Hex:6; HexNAc:5; Neu5Ac:1},3636.574980489754,-8.348917948122618e-06,11.4976236413,69.9318703602,0,20658146.5,86.1970083581,86.4017611093,86.259820475801,3,2,568,578,"sp|Q92835|SHIP1_HUMAN Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 OS=Homo sapiens OX=9606 GN=INPP5D PE=1 SV=2",Unmodified
VQPRVN(N-Glycosylation)VSPSK{Fuc:2; Hex:5; HexNAc:4},3124.3755090625755,1.563710495081469e-06,15.7905923488,19.1698571087,0,308627903.5,59.2732939071,59.904861723,59.489437606557,3,1,121,132,"sp|P04440|DPB1_HUMAN HLA class II histocompatibility antigen, DP beta 1 chain OS=Homo sapiens OX=9606 GN=HLA-DPB1 PE=1 SV=1",Unmodified
N(N-Glycosylation)DSLRK{Fuc:1; Hex:4; HexNAc:3},2134.893925973601,2.8083950521722623e-06,17.119917009,35.3887868232,0,291322209.0,26.0166445559,26.237901126,26.118507840856,2,2,187,193,sp|Q15631|TSN_HUMAN Translin OS=Homo sapiens OX=9606 GN=TSN PE=1 SV=1,Unmodified
TPKIVSGKDYN(N-Glycosylation)VTANSK{Fuc:1; Hex:5; HexNAc:3; Neu5Ac:1},3677.616806525238,5.385276024720435e-07,6.71107183676,10.0397736994,0,16359202.5,84.4433911429,84.6644076731,84.443391142909,3,1,73,90,sp|P00338|LDHA_HUMAN L-lactate dehydrogenase A chain OS=Homo sapiens OX=9606 GN=LDHA PE=1 SV=2,Unmodified
N(N-Glycosylation)ITLDDASAPRLM(Oxidation)VLR{Hex:5; HexNAc:4; Neu5Ac:2},4004.732266540621,-8.635064121799605e-07,11.6715725714,9.09492611607,0,140289823.0,57.7245721247,58.0347107079,57.910112824663,3;4,3,758,774,sp|O75534|CSDE1_HUMAN Cold shock domain-containing protein E1 OS=Homo sapiens OX=9606 GN=CSDE1 PE=1 SV=2,Unmodified
FKLPKFN(N-Glycosylation)FSGSK{Fuc:1; Hex:8; HexNAc:4},3654.58864519,-0.000280383868964,0,8.67114819207,0.0267857142857,0,,,,3,1,3351,3363,sp|Q09666|AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2,
GVKRAN(N-Glycosylation)R{Fuc:1; Hex:5; HexNAc:7},3177.36634102,-3.47422556471e-06,0,10.8473161604,0,0,,,,3,1,363,370,sp|Q13033|STRN3_HUMAN Striatin-3 OS=Homo sapiens OX=9606 GN=STRN3 PE=1 SV=3,
ETPPNGN(N-Glycosylation)LSPAPRLR{Fuc:3; Hex:5; HexNAc:4; Neu5Ac:1},3969.708155260028,3.267853758626289e-07,-21.6338817008,15.1122987618,0,3401308.75,88.9717006233,88.9717006233,88.971700623258,3,3,995,1010,sp|P48634|PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens OX=9606 GN=PRRC2A PE=1 SV=3,Unmodified
N(N-Glycosylation)RSRPPEERPPGLPLPPPPPSSSAVFR{Fuc:1; Hex:8; HexNAc:7; Neu5Ac:2},6379.80015741,-1.69485405876e-06,0,10.9541236794,0,0,,,,4,1,1437,1464,sp|P48634|PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens OX=9606 GN=PRRC2A PE=1 SV=3,
TVN(N-Glycosylation)VSVPKKTR{Fuc:2; Hex:7; HexNAc:5},3669.61033732,5.52350359719e-07,0,16.4345284723,0,0,,,,3,1,88,99,sp|Q96KA5|CLP1L_HUMAN Lipid scramblase CLPTM1L OS=Homo sapiens OX=9606 GN=CLPTM1L PE=1 SV=1,
ADLVN(N-Glycosylation)R{Fuc:2; Hex:5; HexNAc:4},2601.069825587854,-4.855587966994028e-07,11.4729429544,46.9738544328,0,76766142.0,40.700160057,41.0310351597,40.819144791985,2;3,1,374,380,sp|Q8WUM4|PDC6I_HUMAN Programmed cell death 6-interacting protein OS=Homo sapiens OX=9606 GN=PDCD6IP PE=1 SV=1,Unmodified
IEEVVERAN(N-Glycosylation)NTR{Fuc:3; Hex:5; HexNAc:4},3489.5150725,-7.91915164038e-06,0,13.8278758476,0,0,,,,3,1,429,441,"sp|P30837|AL1B1_HUMAN Aldehyde dehydrogenase X, mitochondrial OS=Homo sapiens OX=9606 GN=ALDH1B1 PE=1 SV=4",
FRPLN(N-Glycosylation)ESEVNR{Fuc:2; Hex:5; HexNAc:7},3883.64245672,-4.48098597752e-06,0,11.1585000896,0,0,,,,3,1,14,25,sp|P33176|KINH_HUMAN Kinesin-1 heavy chain OS=Homo sapiens OX=9606 GN=KIF5B PE=1 SV=1,
SQKKM(Oxidation)AN(N-Glycosylation)SSPVLSK{Fuc:2; Hex:5; HexNAc:5},3637.59347686,-3.80796974109e-06,0,18.1949701962,0,0,,,,3,1,209,223,sp|Q9NXE8|CWC25_HUMAN Pre-mRNA-splicing factor CWC25 homolog OS=Homo sapiens OX=9606 GN=CWC25 PE=1 SV=1,
SVKEDSN(N-Glycosylation)LTLQEKK{Fuc:2; Hex:6; HexNAc:4},3694.659050098399,-1.392195996739222e-05,11.5653474939,16.0892837079,0,85883452.0,42.8329609897,43.0274777081,42.923118192577,4;5,1,1442,1456,sp|P46940|IQGA1_HUMAN Ras GTPase-activating-like protein IQGAP1 OS=Homo sapiens OX=9606 GN=IQGAP1 PE=1 SV=1,Unmodified
KLAVGDN(N-Glycosylation)NSKWVK{Hex:4; HexNAc:2},2512.17679407,-3.06230800637e-06,0,11.9301187275,0,0,,,,2,1,674,687,sp|P46940|IQGA1_HUMAN Ras GTPase-activating-like protein IQGAP1 OS=Homo sapiens OX=9606 GN=IQGAP1 PE=1 SV=1,
VLQDELEN(N-Glycosylation)R{Fuc:1; Hex:4; HexNAc:4; Neu5Ac:1},3012.248379017771,-1.466758057579469e-06,12.169783561,83.9320487401,0,148415481.75,39.0379530893,39.5034074094,39.280133842055,3,3,869,878,sp|Q8N8E3|CE112_HUMAN Centrosomal protein of 112 kDa OS=Homo sapiens OX=9606 GN=CEP112 PE=1 SV=2,Unmodified
LKN(N-Glycosylation)ISPK{Fuc:3; Hex:6; HexNAc:6},3427.46325175,-3.31574396471e-09,0,14.4770907365,0,0,,,,3,1,615,622,sp|Q8NDH2|CC168_HUMAN Leucine-rich repeat transmembrane protein CCDC168 OS=Homo sapiens OX=9606 GN=CCDC168 PE=2 SV=3,
M(Oxidation)SLQLYLVDN(N-Glycosylation)R{Hex:5; HexNAc:4},2989.27157002,5.09663492764e-07,0,20.0852101828,0,0,,,,3,1,452,463,sp|P54646|AAPK2_HUMAN 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Homo sapiens OX=9606 GN=PRKAA2 PE=1 SV=2,
M(Oxidation)SLQLYLVDN(N-Glycosylation)R{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},3718.5163882,-0.000267459583797,0,19.2715565378,0,0,,,,3,1,452,463,sp|P54646|AAPK2_HUMAN 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Homo sapiens OX=9606 GN=PRKAA2 PE=1 SV=2,
AN(N-Glycosylation)KTPIR{Fuc:1; Hex:6; HexNAc:6},3135.3398884175954,-5.619087461872668e-06,12.6625657244,87.3946074147,0,129251406.25,78.5413861897,78.8883661256,78.698188625399,3,2,21151,21158,sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4,Unmodified
VHTN(N-Glycosylation)ATIR{Hex:5; HexNAc:4; Neu5Ac:2},3115.2496598837956,6.819330886297187e-06,6.17001083264,12.1004499464,0,44007119.5,71.0083371069,71.5030625409,71.426280890528,3,2,30317,30325,sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4,Unmodified
VFAEN(N-Glycosylation)ETGLSRPR{Fuc:2; Hex:5; HexNAc:5},3592.55427988,-6.8592460798e-06,0,10.9267982852,0,0,,,,3,1,31431,31444,sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4,
EPPSFIKKIEN(N-Glycosylation)TTTVLK{Fuc:3; Hex:5; HexNAc:4},4004.87103817,-5.62465008126e-06,0,10.3871919474,0,0,,,,4,1,5972,5989,sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4,
AELDEVN(N-Glycosylation)KSAK{Fuc:2; Hex:8; HexNAc:5},3806.54243356,1.86920290114e-06,0,13.2154091923,0,0,,,,3,1,125,136,sp|Q03252|LMNB2_HUMAN Lamin-B2 OS=Homo sapiens OX=9606 GN=LMNB2 PE=1 SV=4,
